The use of monoclonal antibodies for purging autologous bone marrow in the lymphoid malignancies.
D000911:Antibodies, Monoclonal / Q000276:immunology; D000951:Antigens, Neoplasm / Q000032:analysis / Q000276:immunology; D000954:Antigens, Surface / Q000032:analysis / Q000276:immunology; D001402:B-Lymphocytes / Q000276:immunology / Q000473:pathology; D016026:Bone Marrow Transplantation / Q000473:pathology*; D002454:Cell Differentiation; D002469:Cell Separation / Q000379:methods*; D003165:Complement System Proteins / Q000276:immunology; D005069:Evaluation Studies as Topic; D006680:HLA Antigens / Q000032:analysis / Q000276:immunology; D006801:Humans; D037102:Lectins / Q000276:immunology; D007945:Leukemia, Lymphoid / Q000473:pathology* / Q000628:therapy; D008223:Lymphoma / Q000473:pathology* / Q000628:therapy; D008280:Magnetics; D010641:Phenotype; D037121:Plant Lectins; D013601:T-Lymphocytes / Q000276:immunology / Q000473:pathology; D014182:Transplantation, Autologous
D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm; D000954:Antigens, Surface; D006680:HLA Antigens; D037102:Lectins; D037121:Plant Lectins; C017707:Ricinus communis agglutinin-1; D003165:Complement System Proteins